]>
IRCT20180120038450N1 IRCT 2018-07-10 Kermanshah University of Medical Sciences A camparative study effectiveness topical minoxidil nanosuspention and minoxidil %2 solution in the treatment of alopecia androgenetic A camparative study effectiveness topical minoxidil nanosuspention and minoxidil 2% solution in the treatment of alopecia androgenetic 2018-06-13 anticipated 140 Complete https://irct.ir/trial/29539 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: 140 patients are randomly divided into two groups of 70 people, Blinding description: In this study, patients, the prescribing physician, the data collector, the prospector who is developing, the one who evaluates the outcomes, and who analyzes the data, are unaware of the type of drug. 3 alopecia areata. Intervention group: Topical minoxidil nanosuspention. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is I have not decided yet. After the study is completed, the results will be publicly available.
public Shahla Mirzaeei
کرمانشاه - بلوار شهید بهشتی - ساختمان مرکزی دانشگاه علوم پزشکی کرمانشاه
Kermanshah Iran (Islamic Republic of) 6734667149 +98 83 3427 6480 shahlamirzaeei@gmail.com Kermanshah University of Medical Sciences scientific Shahla Mirzaeei
14, 11 Abkaei,Bargh, Kermanshah
Kermanshah Iran (Islamic Republic of) 6734667149 +98 83 3824 0526 shahlamirzaeei@gmail.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) 1. Signature of written consent for participation in the study 2-Age between 18-55 years 3-The presence of alopecia androgenetic in male or female 4-There is no other disorder that causes hair loss such as telogeny, echolinate or scarring hair (like lichen planus) Class 1-4 in the Fitzpatrick Classification for Skin Type and Grade 3-6 Hair Loss for Men in the Norwood Hamilton Classification and Grade 2-3 Hair Loss for Women in the Ludwing Classification, Non-Use of Finasteride, Anti-Androgenetics, Local Estrogen , Progesterone, tamoxifen, anabolic steroids, potent potent medications for hyperkeratosis, oral glucocorticoid, lithium, phenothiazines within 3 months before the start of the study 18 years 55 years Both 1-Pregnancy 2-lactation 3-Using of anabolic steroids in the last 6month 4-Using of topical minoxidil in the last 6month 5-Using of antiandrogenetic drugs in the last 6 month 6-Using of the drugs who make hyper keratosis as like as systemic corticosteroids in the last 6 month 7-Dont be principled to curative protocol 8-Hair transplantation 9-Collagen vascular disease or HIV 10-Endocrinopathy like PCO, Hypotyroid Treatment - Drugs Intervention group: Topical minoxidil nanosuspention Hair density. Timepoint: 0,2,4,6 months. Method of measurement: Phototyrographic method. Diagonal hair shaft. Timepoint: 0,2,4,6. Method of measurement: Phototyrographic method. Patient satisfaction. Timepoint: 2,4,6 months. Method of measurement: questionnaire. Headache. Timepoint: 2,4,6 months. Method of measurement: Ask the patient. Erythema - redness-itching. Timepoint: 0,2,4,6 month. Method of measurement: Ask the patient. Hypopigmentation, hyperpigmentation. Timepoint: 0,2,4,6 month. Method of measurement: Evaluate by observation and Ask the patient. Kermanshah University of Medical Sciences Approved 2018-06-13 Ethics committee of Kermanshah University of Medical Sciences Central Office of Kermanshah University of Medical Sciences-Shahid Beheshti Blvd. Kermanshah Kermanshah Iran (Islamic Republic of)